| The lineage determining factor GRHL2 collaborates with FOXA1 to establish a targetable pathway in endocrine therapy-resistant breast cancer KJ Cocce, JS Jasper, TK Desautels, L Everett, S Wardell, T Westerling, ... Cell reports 29 (4), 889-903. e10, 2019 | 51 | 2019 |
| Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma B Chakraborty, J Byemerwa, J Shepherd, CN Haines, R Baldi, W Gong, ... The Journal of clinical investigation 131 (23), 2021 | 48 | 2021 |
| G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer KJ Andreano, SE Wardell, JG Baker, TK Desautels, R Baldi, CA Chao, ... Breast cancer research and treatment 180, 635-646, 2020 | 43 | 2020 |
| Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in … SE Wardell, AP Yllanes, CA Chao, Y Bae, KJ Andreano, TK Desautels, ... Breast cancer research and treatment 179, 67-77, 2020 | 37 | 2020 |
| Early adversity promotes binge-like eating habits by remodeling a leptin-responsive lateral hypothalamus–brainstem pathway S Shin, IJ You, M Jeong, Y Bae, XY Wang, ML Cawley, A Han, BK Lim Nature Neuroscience 26 (1), 79-91, 2023 | 11 | 2023 |
| Measuring the impact of targeting FcRn-mediated IgG recycling on donor-specific alloantibodies in a sensitized NHP model M Manook, WJ Flores, R Schmitz, Z Fitch, J Yoon, Y Bae, B Shaw, A Kirk, ... Frontiers in Immunology 12, 660900, 2021 | 9 | 2021 |
| Belatacept-based maintenance immunosuppression controls the post-transplant humoral immune response in highly sensitized nonhuman primates R Schmitz, ZW Fitch, M Manook, PM Schroder, AY Choi, D Olaso, J Yoon, ... Kidney360 3 (12), 2116-2130, 2022 | 5 | 2022 |
| Lateral hypothalamic proenkephalin neurons drive threat-induced overeating associated with a negative emotional state IJ You, Y Bae, AR Beck, S Shin Nature Communications 14 (1), 6875, 2023 | 2 | 2023 |
| Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant M Manook, D Olaso, IJ Anwar, J Yoon, I Delaura, Y Bae, D Moris, B Shaw, ... Science Advances 9 (20), eadg1448, 2023 | 2 | 2023 |
| Abstract ND02: Discovery of BMS-986365, a ligand-directed androgen receptor degrader (AR LDD) with a dual mechanism-of-action and best-in-class potential, for the treatment of … S Xu, S Nayak, JD Norris, M Ammirante, E Rychak, SE Wardell, T Tsuji, ... Cancer Research 84 (7_Supplement), ND02-ND02, 2024 | | 2024 |
| Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model R Schmitz, M Manook, Z Fitch, I Anwar, I DeLaura, D Olaso, A Choi, ... Frontiers in Transplantation 2, 1230393, 2023 | | 2023 |
| Belatacept and Carfilzomib-based Treatment of Active Antibody-mediated Rejection in a Sensitized Nonhuman Primate Model J Kwun, R Schmitz, M Manook, Z Fitch, D Olaso, A Choi, J Yoon, Y Bae, ... AMERICAN JOURNAL OF TRANSPLANTATION 21, 476-476, 2021 | | 2021 |
| Impact of Allosensitization on Xenotransplantation D Olaso, M Manook, J Yoon, Y Bae, A Barbas, A Adams, S Knechtle, ... AMERICAN JOURNAL OF TRANSPLANTATION 21, 477-478, 2021 | | 2021 |
| Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-alpha degrader activity in … SE Wardell, AP Yllanes, CA Chao, Y Bae, KJ Andreano, TK Desautels, ... BREAST CANCER RESEARCH AND TREATMENT 179 (3), 769-769, 2020 | | 2020 |
